City

Houston (1)

Sacramento (1)

Condition

Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck (2)

Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 (2)

Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck (1)

Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck (1)

Stage II Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 (1)

Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 (1)

Overall Status

Recruiting (2)

Sign in for free

Phase

phase 2 (2)

Sponsor

Arnaud Bewley (1)

M.D. Anderson Cancer Center (1)

Collaborator

National Cancer Institute (NCI) (2)

Genentech, Inc. (1)

Intervention

atezolizumab (1)

cemiplimab (1)

radiation therapy (1)

therapeutic conventional surgery (1)

Study Documents

Intervention Type

biological (2)

procedure (1)

radiation (1)

Funder Type

Other (2)

Study Type

Interventional (2)

resectable cutaneous squamous cell carcinoma of the head and neck

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck, Resectable Cutaneous Squamous Cell Carcinoma of the Head and

Recruiting

Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck
+4 more

Cemiplimab

Houston, Texas

M D Anderson Cancer Center

Jan 17, 2023

Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck, Resectable Cutaneous Squamous Cell Carcinoma of the

Recruiting

Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck
+2 more

Atezolizumab
+2 more

Sacramento, California

University of California Davis Comprehensive Cancer Center

Jan 19, 2022